Stanford researchers have developed a new class of materials that enable new strategies for the efficient delivery of messenger RNA (mRNA) into cells and animals. The delivery materials are easily prepared (2 steps), stable and readily tuned.
This invention is from the Pritzker Neuropsychiatric Disorders Research Consortium, a collaborative research enterprise comprised of several leading academic institutions and based on a long-term relationship between the Pritzker family and scientists at the various institutio
Stanford researchers have built a sound powered, wireless medical implant. The implant contains a piezoelectric energy receiver, an integrated circuit chip, and a loop antenna.
Researchers at Stanford University have developed a newly patented method for reducing the physiological symptoms of opioid withdrawal by targeting a well-characterized receptor.
Stanford researchers have developed a gene therapy that combines a retinal ganglion cell (RGC)- specific promoter with CRISPR gene editing to provide effective neuroprotection in optic neuropathies.
Stanford researchers have engineered an exceptionally bright, cyan-excitable orange-red fluorescent protein (CyOFP) that can be used both for multiplex imaging with GFP and for high-sensitivity, bioluminescent in vivo imaging.
We created a transgenic mouse on the FVB background in which the transgene is comprised of a strong constitutive promoter (CAG) driving expression of a dual reporter gene (luciferase and GFP). We called the original FVB mouse L2G85.
Researchers at Stanford have developed chimeric antigen receptors (CARs) that target glypican-2 (GPC2) and can be used to treat solid tumors. CAR-engineered T cells have shown great promise as cancer therapeutics.
Researchers at Stanford have developed a combination therapy to treat neuroblastoma, the most common and deadly solid tumor in childhood. Neuroblastoma derives from neural crest cells that fail to exit the cell cycle and differentiate.
Stanford researchers have developed and validated a quality assurance (QA) phantom that will facilitate the translation of a frameless volumetric modulated arc therapy radiosurgery technique.
Stanford researchers in Professor Rhiju Das's lab have devised a method called RNAMake to optimize nucleic acids, such as aptamers and messenger RNAs, and enhance their effectiveness for clinical settings.
This software tool takes clinical notes from veterinary electronic medical records and assigns SNOMED-CT VET extension diagnostic codes based on the content written on the notes.